During the last session, Black Diamond Therapeutics Inc (NASDAQ:BDTX)’s traded shares were 0.57 million, with the beta value of the company hitting 2.60. At the end of the trading day, the stock’s price was $5.89, reflecting an intraday gain of 15.26% or $0.78. The 52-week high for the BDTX share is $6.85, that puts it down -16.3 from that peak though still a striking 75.72% gain since the share price plummeted to a 52-week low of $1.43. The company’s market capitalization is $304.63M, and the average trade volume was 644.93K shares over the past three months.
Black Diamond Therapeutics Inc (NASDAQ:BDTX) trade information
Black Diamond Therapeutics Inc (BDTX) registered a 15.26% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 15.26% in intraday trading to $5.89, hitting a weekly high. The stock’s 5-day price performance is 11.98%, and it has moved by 20.20% in 30 days. Based on these gigs, the overall price performance for the year is 300.68%.
Black Diamond Therapeutics Inc (BDTX) estimates and forecasts
Statistics show that Black Diamond Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. Black Diamond Therapeutics Inc (BDTX) shares have gone up 208.38% during the last six months, with a year-to-date growth rate less than the industry average at 9.04% against 10.40.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -49.79%. While earnings are projected to return 8.95% in 2024.
BDTX Dividends
Black Diamond Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
